US2012083855A1PendingUtilityA1
Gi and pancreatic device for treating obesity and diabetes
Est. expiryJul 13, 2025(expired)· nominal 20-yr term from priority
A61N 1/36007
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method is provided, including placing first and second electrodes at respective first and second sites of a duodenum of a subject, and activating the electrodes to increase a blood insulin level of the subject. Other embodiments are also described.
Claims
exact text as granted — not AI-modified1 . An apparatus comprising:
one or more electrodes, adapted to be placed in contact with a wall of a duodenum of a subject; and a control unit, adapted to:
drive the electrodes to apply a current to the wall of the duodenum,
configure the current to stimulate a site selected from the group consisting of:
a vagus nerve of the subject, and enteric nervous system (ENS) tissue of the subject,
configure the current in accordance with a set of parameters for the current, the set of parameters including a pulse width of pulses of the current and a frequency of application of the pulses, and
select the set of parameters to be such as to lower a level of glucose in blood of the subject and to be sufficient to cause closure of a pylorus of the subject.
2 . A method comprising:
applying a current to a wall of a duodenum of a subject; configuring the current to stimulate a site selected from the group consisting of: a vagus nerve of the subject, and enteric nervous system (ENS) tissue of the subject, in accordance with a set of parameters for the current, the set of parameters including a pulse width of pulses of the current and a frequency of application of the pulses; and selecting the set of parameters to be such as to lower a level of glucose in blood of the subject and to be sufficient to cause closure of a pylorus of the subject.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.